RARE
Ultragenyx
15.50$
+1.2%
vs. previous close
Closing price · As of: Oct 9, 2026
Statements
Income Statement
All figures per share in USD.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1.37 | 1.57 | 1.29 | 1.70 | 1.46 | 1.72 | 1.45 | 1.69 | 1.60 | 2.07 | 1.35 | 2.10 | 7.04 | |
| 0.15 | 0.15 | 0.21 | 0.25 | 0.22 | 0.18 | 0.30 | 0.23 | 0.28 | 0.29 | 0.30 | 0.33 | 1.19 | |
| 1.21 | 1.42 | 1.08 | 1.45 | 1.24 | 1.55 | 1.15 | 1.46 | 1.32 | 1.78 | 1.05 | 1.77 | 5.85 | |
| 2.19 | 1.98 | 2.12 | 1.87 | 1.78 | 1.96 | 1.72 | 1.67 | 2.17 | 2.03 | 1.86 | 1.64 | 7.59 | |
| 1.05 | 0.95 | 0.93 | 0.93 | 0.84 | 0.86 | 0.91 | 0.88 | 0.87 | 0.88 | 0.87 | 0.86 | 3.44 | |
| 3.24 | 2.93 | 3.04 | 2.80 | 2.62 | 2.82 | 2.63 | 2.55 | 3.04 | 2.92 | 2.73 | 2.50 | 11.04 | |
| -2.02 | -1.50 | -1.96 | -1.34 | -1.38 | -1.28 | -1.48 | -1.10 | -1.71 | -1.14 | -1.68 | -0.74 | -5.19 | |
| 0.25 | 0.21 | 0.19 | 0.18 | 0.16 | 0.16 | 0.15 | 0.14 | 0.14 | 0.19 | 0.21 | 0.22 | 0.75 | |
| -2.22 | -1.56 | -2.02 | -1.51 | -1.39 | -1.39 | -1.56 | -1.16 | -1.80 | -1.28 | -1.83 | -0.89 | -5.72 | |
| 0.01 | -0.05 | 0.01 | 0.01 | 0.00 | 0.00 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.04 | |
| -2.23 | -1.52 | -2.03 | -1.52 | -1.40 | -1.39 | -1.57 | -1.17 | -1.81 | -1.29 | -1.84 | -0.90 | -5.75 | |
| -1.87 | -1.25 | -1.73 | -1.22 | -1.14 | -1.14 | -1.31 | -0.93 | -1.57 | -1.00 | -1.54 | -0.60 | -4.64 |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 9, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.